Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes

Cellular Mechanisms of Tissue Fibrosis. 5. Novel insights into liver fibrosis

(2013) Ariane Mallat et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling

(2012) Kento Imajo et al.   Cell Metabolism

Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α

(2012) Keitaro Kanda et al.   EMBO Molecular Medicine

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

(2010) Z. M. YOUNOSSI   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

(2010) Eek Joong Park et al.   CELL

c-Jun N-terminal Kinase-1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in Mice

(2009) Yuzo Kodama et al.   GASTROENTEROLOGY

Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model

(2009) Hiroshi Kudo et al.   JOURNAL OF HEPATOLOGY

Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system

(2009) Mikiko Ohno et al.   NATURE NEUROSCIENCE

Ectodomain shedding of TNF-α is enhanced by nardilysin via activation of ADAM proteases

(2008) Yoshinori Hiraoka et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease

(2008) K Fujita et al.   GUT